Patient Portal

Jeff M. Michalski, MD, MBA

Professor, Radiation Oncology
Vice Chairman, Radiation Oncology
Chief, Genitourinary Service

Specialty Areas

Radiation Oncology
Genitourinary Oncology
Sarcoma
Prostate Cancer
Intensity Modulated Radiation Therapy ( IMRT)
Pediatric Radiation Oncology

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish Hospital
St. Louis Children's Hospital
Christian Hospital
Barnes-Jewish West County Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Radiation therapy, radiation oncology, pediatric oncology, prostate conditions, prostate cancer, treatment planning, carcinoma of the prostate, conformal radiation therapy, prostate brachytherapy

  • Location(s)
  • Education
  • Publication & Research

Location(s)

Location(s)

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110

Floor: LL
Office Phone: 314-747-7236
Fax: 314-747-9557

Christian Hospital

11133 Dunn Road
St. Louis, MO 63136

Office Phone: 314-653-5255
Fax: 314-653-4283

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129

Education

Education

Instructor - Fellow: Washington University School of Medicine, Radiation Oncology Center, St. Louis, MO 1991
Resident: Radiation Oncology, Washington University School of Medicine, St. Louis, MO. 1990
Resident: Radiation Oncology, Columbia-Presbyterian Medical Center 1988
Medical Degree: Medical College Of Wisconsin 1986
B.S. Biochemistry: University of Wisconsin-Madison 1982

Publication & Research

Publication & Research

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy.
Baumann BC, Hallahan DE, Michalski JM, Perez CA, Metz JM
Br J Cancer. 2020 Jun 18; doi: 10.1038/s41416-020-0919-2.

PMID:
    32555364
    [PubMed - as supplied by publisher]
Related citations


ACR-ASTRO Practice Parameter for Communication: Radiation Oncology.
Schechter NR, Brown DW, Bovi JA, Dominello MM, Liu AK, Mattes MD, Michalski JM, Shih HA, Strom E, Wilkinson JB, Rosenthal SA, Hartford A
Am J Clin Oncol. 2020 Jun 5; doi: 10.1097/COC.0000000000000707.

PMID:
    32520791
    [PubMed - as supplied by publisher]
Related citations


Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
Mir R, Kelly SM, Xiao Y, Moore A, Clark CH, Clementel E, Corning C, Ebert M, Hoskin P, Hurkmans CW, Ishikura S, Kristensen I, Kry SF, Lehmann J, Michalski JM, Monti AF, Nakamura M, Thompson K, Yang H, Zubizarreta E, Andratschke N, Miles E
Radiother Oncol. 2020 Jun 3; 15030-39. doi: 10.1016/j.radonc.2020.05.038.

PMID:
    32504762
    [PubMed - as supplied by publisher]
Related citations


Comparative genomic analysis provides insight into the phylogeny and virulence of atypical enteropathogenic Escherichia coli strains from Brazil.
Hernandes RT, Hazen TH, Dos Santos LF, Richter TKS, Michalski JM, Rasko DA
PLoS Negl Trop Dis. 2020 Jun; 14(6)e0008373. doi: 10.1371/journal.pntd.0008373.

PMID:
    32479541
    [PubMed - in process]
Related citations


Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.
Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ
Cancer. 2020 Jun 1; doi: 10.1002/cncr.32969.

PMID:
    32478867
    [PubMed - as supplied by publisher]
Related citations


Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.
Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE
JAMA Oncol. 2020 Mar 26; doi: 10.1001/jamaoncol.2020.0109.

PMID:
    32215583
    [PubMed - as supplied by publisher]
Related citations


Bone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario Guideline.
Saylor PJ, Rumble RB, Michalski JM
JCO Oncol Pract. 2020 Feb 19; JOP1900778. doi: 10.1200/JOP.19.00778.

PMID:
    32074010
    [PubMed - as supplied by publisher]
Related citations


Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline.
Saylor PJ, Rumble RB, Tagawa S, Eastham JA, Finelli A, Reddy PS, Kungel TM, Nissenberg MG, Michalski JM
J Clin Oncol. 2020 May 20; 38(15)1736-1743. doi: 10.1200/JCO.19.03148.

PMID:
    31990618
    [PubMed - in process]
Related citations


A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate.
Fischer-Valuck BW, Gay HA, Patel S, Baumann BC, Michalski JM
Front Oncol. 2019; 91378. doi: 10.3389/fonc.2019.01378.

PMID:
    31921640
    [PubMed]
Related citations


Examination of 388 Staphylococcus aureus Isolates from Intensive Care Unit Patients.
Adedrian T, Hitchcock S, O'Hara LM, Michalski JM, Johnson JK, Calfee DP, Miller LG, Hazen TH, Rasko DA, Harris AD
Microbiol Resour Announc. 2019 Nov 14; 8(46)pii: e01246-19. doi: 10.1128/MRA.01246-19.

PMID:
    31727718
    [PubMed]
Related citations


Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma.
Brenneman RJ, Sharifai N, Fischer-Valuck B, Hassanzadeh C, Guzelian J, Chrisinger JSA, Michalski JM, Oppelt P, Baumann BC
Front Oncol. 2019; 9922. doi: 10.3389/fonc.2019.00922.

PMID:
    31616634
    [PubMed]
Related citations


Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer.
Barnes J, Kennedy WR, Fischer-Valuck BW, Baumann BC, Michalski JM, Gay HA
J Contemp Brachytherapy. 2019 Aug; 11(4)320-328. doi: 10.5114/jcb.2019.86974.

PMID:
    31523232
    [PubMed]
Related citations


Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer.
Spratt DE, Michalski JM
Int J Radiat Oncol Biol Phys. 2019 Jul 15; 104(4)798-800. doi: 10.1016/j.ijrobp.2019.04.001.

PMID:
    31204661
    [PubMed - indexed for MEDLINE]
Related citations


Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients.
Michalski JM, Lyden ER, Lee AJ, Al-Kadhimi ZS, Maness LJ, Gundabolu K, Bhatt VR
Future Oncol. 2019 Jun; 15(17)1989-1995. doi: 10.2217/fon-2019-0001.

PMID:
    31170814
    [PubMed - indexed for MEDLINE]
Related citations


Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
Fischer-Valuck BW, Michalski JM, Mitra N, Christodouleas JP, DeWees TA, Kim E, Smith ZL, Andriole GL, Arora V, Bullock A, Carmona R, Figenshau RS, Grubb RL, Guzzo TJ, Knoche EM, Malkowicz SB, Mamtani R, Pachynski RK, Roth BJ, Zaghloul MS, Gay HA, Baumann BC
Cancer Med. 2019 Jul; 8(8)3698-3709. doi: 10.1002/cam4.2102.

PMID:
    31119885
    [PubMed - in process]
Related citations


Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM
Radiother Oncol. 2019 Jun; 13519-24. doi: 10.1016/j.radonc.2019.02.014.

PMID:
    31015166
    [PubMed - indexed for MEDLINE]
Related citations


Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.
Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM
J Clin Oncol. 2019 May 10; 37(14)1159-1168. doi: 10.1200/JCO.18.02158.

PMID:
    30860948
    [PubMed - indexed for MEDLINE]
Related citations


Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B
JAMA Oncol. 2019 May 1; 5(5)664-670. doi: 10.1001/jamaoncol.2018.6752.

PMID:
    30763425
    [PubMed - indexed for MEDLINE]
Related citations


Clinical Outcomes and Prognostic Features of Angiosarcoma: Significance of Prior Radiation Therapy.
Merfeld E, Gabani P, Spraker MB, Zoberi I, Kim H, Van Tine B, Chrisinger J, Michalski JM
Clin Oncol (R Coll Radiol). 2019 Apr; 31(4)232-241. doi: 10.1016/j.clon.2019.01.006.

PMID:
    30718086
    [PubMed - indexed for MEDLINE]
Related citations


NCTN Assessment on Current Applications of Radiomics in Oncology.
Nie K, Al-Hallaq H, Li XA, Benedict SH, Sohn JW, Moran JM, Fan Y, Huang M, Knopp MV, Michalski JM, Monroe J, Obcemea C, Tsien CI, Solberg T, Wu J, Xia P, Xiao Y, El Naqa I
Int J Radiat Oncol Biol Phys. 2019 Jun 1; 104(2)302-315. doi: 10.1016/j.ijrobp.2019.01.087.

PMID:
    30711529
    [PubMed - indexed for MEDLINE]
Related citations